We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bodycote Plc | LSE:BOY | London | Ordinary Share | GB00B3FLWH99 | ORD 17 3/11P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-12.00 | -1.85% | 637.00 | 640.00 | 641.00 | 651.00 | 638.00 | 651.00 | 279,331 | 16:35:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Metalworking Machinery, Nec | 802.5M | 85.6M | 0.4583 | 13.96 | 1.21B |
PR Newswire
LONDON, United Kingdom, December 12
12 December 2024
Bodycote plc
Capital Markets Event
Optimise, Perform, Grow
Bodycote, the world's leading provider of precision heat treatment and specialist thermal processing services, will today host a Capital Markets Event for analysts and institutional investors in London.
Jim Fairbairn, Chief Executive Officer and Ben Fidler, Chief Financial Officer will host the event, with additional presentations from Bodycote’s leadership team. They will set out plans and actions to deliver sustainable improvements in the quality, performance and growth outlook for the business, as well as setting new financial targets.
Chief Executive Officer, Jim Fairbairn said:
“Today we are presenting a clear vision to create an optimised, efficient and high-performance Bodycote, which will deliver sustainably stronger growth with improved profitability and resilience through the cycle.”
“We are establishing a set of compelling and achievable financial targets. We are confident in our ability to achieve these ambitions and have a clear plan to deliver on our targets. This will benefit not just our shareholders but our people, customers and partners. We are building a company that can fully realise its potential, and ensure that Bodycote’s excellence endures long into the future.”
Two high quality platforms – Specialist Technologies and Precision Heat Treatment
We will drive improved growth and performance from two new, redefined global divisions:
We will begin reporting on this new basis at our full year 2024 results in March 2025.
Three levers to drive strategic execution
Our plan to deliver Bodycote’s full potential from these two leading divisions will be executed through three principal strategic levers:
Accelerating via sustainability
Our capabilities enable us to play a meaningful role in the transition to a low carbon future, which will act as a key accelerator to our strategy. We have already made significant progress in this area and today are announcing three new sustainability targets:
Ambitious financial targets announced, underpinned by our strategy
Driven by our strategic actions, we are setting out new financial targets for the Group:
1 Specialist Technologies re-defined to exclude Low Pressure Carburising (LPC) and Corr-I-Dur ® , now reported within Precision Heat Treatment
Capital Allocation and £30m extension of our current share buyback programme
A disciplined approach to capital allocation remains a central element of our strategy, encompassing organic growth, dividends, acquisitions and additional shareholder returns when appropriate. Progress has been made year to date on the £60m share buyback programme. Since the buyback commenced in March 2024, a cumulative 8.1m shares have been repurchased under the programme for a total spend to date of £54.4m.
The Group’s balance sheet is strong. As disclosed in our 19 November 2024 trading update, net debt (excluding IFRS16 lease liabilities) was £70m at 31 October 2024, equating to leverage of approximately 0.45x net debt/EBITDA.
We see a range of appealing organic investment opportunities to grow the business in line with our strategy and continue to evaluate acquisition opportunities as they become available. Our primary focus in the near term is on the execution and delivery of our plan. Reflecting this focus and the strength of our balance sheet, we are announcing today our intention to extend our existing £60m share buyback programme by a further £30m. This will be executed during 2025.
Financial impact of optimisation actions
We will be undertaking a number of optimisation actions to drive step changes and improvements across the business. We expect these to deliver an ongoing annual operating profit benefit of £12-14m, once the programme is complete by the end of 2026.
The optimisation of our plant footprint and associated plant closures, together with overhead cost reduction actions, will lead to an exceptional net cash cost of c. £25-30m. We expect an exceptional P&L charge of c.£60m, with an additional c.£12-15m goodwill write-down related to our North America Automotive and Industrial focused operations. The majority of the exceptional P&L charge and cash costs will be incurred across 2024 and 2025. For a temporary period we will also be reporting a small non-core division as we progress with the optimisation programme.
Current trading
Current trading remains in line with that disclosed in our 19 November 2024 trading update, and our full year expectations remain unchanged. The Group will not be providing any new information on current trading at today’s event.
For further information, please contact:
Bodycote plc
Jim Fairbairn, Chief Executive Officer
Ben Fidler, Chief Financial Officer
Peter Lapthorn, Investor Relations and FP&A
Tel: +44 1625 505 300
FTI Consulting
Richard Mountain
Susanne Yule
Tel: +44 203 727 1340
Post-event recording and presentation
For those unable to attend the in-person event, there will be a post-event recording available which can be accessed from 17 December 2024 using the following webcast link: https://www.bodycote.com/investors/capital-markets-event-2024/
A copy of all the presentation materials will be made available on the Group’s investor relations website from 14.00 on 12 December 2024.
Disclosures:
This announcement contains inside information for the purposes of Article 7 of Regulation 2014/596/EU which is part of UK domestic law pursuant to the Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310) ("UK MAR"). Upon the publication of this announcement, this inside information (as defined in UK MAR) is now considered to be in the public domain.
This announcement contains forward-looking statements based on current expectations and assumptions. Various known and unknown risks, uncertainties and other factors may cause actual results to differ from future results or developments expressed or implied from the forward-looking statements. Each forward-looking statement speaks only as of the date of this document. Bodycote plc accepts no obligation to revise or update these forward-looking statements publicly or adjust them to future events or developments, whether as a result of new information, future events or otherwise, except to the extent legally required.
1 Year Bodycote Chart |
1 Month Bodycote Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions